As a consequence of diverse pharmacokinetic profiles, oral formulations usually are not interchangeable with extended launch on an mg-mg foundation due to different pharmacokinetic profiles Could be provided as monotherapy or as adjunctive therapy with stimulants. The extended-launch will not